A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers

Trial Profile

A Prospective, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial Comparing Two Doses of VF001-DP to Placebo as an Adjunct to Standard Care in Patients With Chronic Venous Leg Ulcers

Recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs VF 001 (Primary)
  • Indications Varicose ulcer
  • Focus Therapeutic Use
  • Sponsors Factor Therapeutics
  • Most Recent Events

    • 30 Nov 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
    • 30 Nov 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Aug 2018.
    • 05 Oct 2017 According to a Factor Therapeutics media release, the company has added four new sites into the trial, one in California, one in Florida and two in Puerto Rico.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top